CD44 and PTGS2 Methylation are Independent Prognostic Markers for Biochemical Recurrence Among Prostate Cancer Patients with Clinically Localized Disease
Authors:
- Karen WoodsonKWKaren Woodson
- Keith J O’rEillyKOKeith J O’rEilly
- David E WardDWDavid E Ward
- Jack WalterJWJack Walter
- Jeffery HansonJHJeffery Hanson
- Elyse L WalkEWElyse L Walk
- Joseph A TangreaJTJoseph A Tangrea
- 23 October 2006
- journal article
- Published by Taylor & Francis in Epigenetics
- Vol. 1 (4) , 183-186